PharmaCyte Biotech Inc. (PMCB)
1.59
-0.05 (-3.05%)
At close: Mar 13, 2025, 1:39 PM
PharmaCyte Biotech Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.16K | 66.56K | 126K | 262.93K | 653.13K | 1.19M | 1.17M | 537.04K | 86.37K | 2.38K | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.62K | 19.38K | 32.1K | 228.66K | 427.41K | 266.2K | 171.01K | n/a | 41.4K | 780.00 | n/a | n/a |
| Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.54K | 47.17K | 93.89K | 34.27K | 225.72K | 923.75K | 998.65K | 537.04K | 44.97K | 1.6K | n/a | n/a |
| Operating Income | -6.52M | -6.46M | -4.39M | -3.62M | -3.83M | -4.1M | -6.98M | -4.44M | -6.07M | -13.7M | -18.98M | -1.68M | -1.95M | -388.36K | -2.11M | -6.04M | -3.75M | -3.61M | -7.34M | -4.16M | -1.72M | -32.13K | -29.85K |
| Interest Income | 3.4M | 1.94M | 157.65K | 3.05 | 0.45 | n/a | n/a | n/a | n/a | n/a | 1.09K | n/a | n/a | n/a | n/a | 14.65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | 333.76K | -4.32M | -4.24M | -3.55M | -3.83M | -4.07M | -6.83M | -4.44M | -6.06M | -10.85M | -27.25M | -1.6M | -1.66M | -1.23M | -5.7M | -6.03M | -3.82M | -3.6M | -9.03M | -4.15M | n/a | n/a | n/a |
| Net Income | 333.76K | -4.32M | -4.09M | -3.55M | -3.83M | -4.07M | -6.83M | -4.44M | -6.06M | -10.85M | -27.25M | -1.6M | -1.9M | -1.4M | -5.99M | -6.04M | -3.79M | -3.61M | -9.39M | -4.28M | -1.72M | -32.13K | -29.85K |
| Selling & General & Admin | 2.12M | 5.99M | 3.7M | 2.71M | 3.53M | 3.64M | 4.98M | 3.26M | 4.67M | 10.22M | 18.98M | 1.69M | 2M | 473.05K | 1.65M | 5.79M | 4.26M | 4.47M | 7.75M | 3.1M | 313.94K | 32.13K | n/a |
| Research & Development | 407.43K | 468.54K | 690.94K | 916.25K | 301.22K | 460.05K | 2M | 1.18M | 1.41M | 3.48M | 323.50 | n/a | n/a | 9.21K | 492.46K | 473.51K | 412.88K | 133.84K | 119.01K | 1.11M | 1.41M | n/a | n/a |
| Other Expenses | n/a | 202K | -4.28K | -1.19K | -40 | 33.4K | 152.59K | 2.52M | 10.54K | 3.34M | -5.89M | 2.59K | 1.22M | 103.9K | n/a | 4.07M | n/a | n/a | n/a | n/a | n/a | n/a | 29.85K |
| Operating Expenses | 8.52M | 6.46M | 4.39M | 3.62M | 3.83M | 4.1M | 6.98M | 4.44M | 6.07M | 13.7M | 18.98M | 1.69M | 2M | 482.25K | 2.14M | 6.27M | 4.67M | 4.61M | 7.87M | 4.21M | 1.72M | 32.13K | 29.85K |
| Interest Expense | n/a | n/a | 509.00 | 3.05K | 453.00 | n/a | n/a | 1.54K | 1.19K | 4.94K | 21.05K | 154.42K | 241.25K | 171.66K | 292.56K | 27.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 230.5K | 872.2K | 106.41K | 11.15K | 10.83K | 411.72K | 594.34K | n/a | n/a | 1.19M | n/a | n/a | n/a | n/a |
| Cost & Expenses | 6.52M | 6.46M | 4.39M | 3.62M | 3.83M | 4.1M | 6.98M | 4.44M | 6.07M | 13.7M | 18.98M | 1.7M | 2.02M | 514.36K | 2.37M | 6.7M | 4.94M | 4.78M | 7.87M | 4.25M | 1.72M | 32.13K | 29.85K |
| Income Tax | n/a | -1.94M | -153.36K | 3.05K | 453.00 | -33.4K | -152.59K | -4.44K | -4.88K | 4.94K | 19.96K | 154.42K | -49.87K | 1.01M | 3.88M | -471 | 42.72K | 6.79K | 2.05M | 114.04K | 1.72M | 32.13K | 29.85K |
| Shares Outstanding (Basic) | 9.58M | 19.49M | 15.52M | 1.45M | 903.81K | 733.4K | 645.76K | 563.54K | 501.6K | 469.79K | 389.01K | 294.12K | 249.97K | 233.68K | 200.97K | 134.68K | 112.01K | 108.34K | 91.16K | 69.27K | 62.95K | 58.7K | 58.7K |
| Shares Outstanding (Diluted) | 9.58M | 19.49M | 15.52M | 1.45M | 903.81K | 733.4K | 646.08K | 563.82K | 501.85K | 469.79K | 389.01K | 294.12K | 249.97K | 233.68K | 200.97K | 134.68K | 112.01K | 108.34K | 91.16K | 69.27K | 62.95K | 58.7K | 58.7K |
| EPS (Basic) | -1.8 | -0.22 | -0.26 | -2.46 | -4.23 | -5.55 | -10.57 | -7.89 | -12.09 | -23.11 | -70.06 | -5.43 | -7.6 | -5.98 | -29.81 | -44.86 | -33.86 | -33.36 | -102.95 | -61.74 | -27.4 | -0.55 | -0.51 |
| EPS (Diluted) | -1.8 | -0.22 | -0.26 | -2.46 | -4.23 | -5.55 | -10.57 | -7.88 | -12.08 | -23.11 | -70.06 | -5.43 | -7.6 | -5.98 | -29.81 | -44.86 | -33.86 | -33.36 | -102.95 | -61.74 | -27.4 | -0.55 | -0.51 |
| EBITDA | n/a | n/a | n/a | n/a | -3.83M | n/a | n/a | -4.44M | n/a | -9.92M | -27.23M | -1.68M | -1.63M | -388.36K | -2.11M | -5.99M | -3.78M | -3.61M | -7.33M | -1.72M | -1.73M | -32.13K | -29.85K |
| Depreciation & Amortization | n/a | 6.46M | 4.39M | 3.62M | 3.83M | 4.1M | 6.98M | 4.44M | 6.07M | 492.05K | -5.89M | 2.59K | 24.66K | 40.69K | 114.91K | 28.83K | 6.38K | 1.35K | 488.00 | 23.26K | n/a | n/a | n/a |